GENKYOTEX
Genkyotex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals. Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy, giving them a significant competitive advantage. Genkyotex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.
GENKYOTEX
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.genkyotex.com
Total Employee:
11+
Status:
Active
Contact:
141228801013
Email Addresses:
[email protected]
Total Funding:
87.15 M USD
Technology used in webpage:
SPF LetsEncrypt Domain Not Resolving Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS DMARC Google Analytics Event Tracking FLoC Opt-Out
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-02-28 | Genticel | Genticel acquired by Genkyotex | N/A |
Investors List
VI Partners
VI Partners investment in Post-IPO Equity - Genkyotex
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Post-IPO Equity - Genkyotex
Neomed Management
Neomed Management investment in Post-IPO Equity - Genkyotex
Andera Partners
Andera Partners investment in Post-IPO Equity - Genkyotex
Eclosion SA
Eclosion SA investment in Post-IPO Equity - Genkyotex
BioMedPartners
BioMedPartners investment in Post-IPO Equity - Genkyotex
Edmond de Rothschild Private Equity
Edmond de Rothschild Private Equity investment in Post-IPO Equity - Genkyotex
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series C - Genkyotex
Andera Partners
Andera Partners investment in Series C - Genkyotex
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series C - Genkyotex
Official Site Inspections
http://www.genkyotex.com
- Host name: plo14-18.drugdesigntech.com
- IP address: 185.172.102.18
- Location: Geneva Switzerland
- Latitude: 46.1917
- Longitude: 6.1361
- Timezone: Europe/Zurich
- Postal: 1227
